Drug GMPs
| GMP International Master Reference Guide |
| 21 CFR 210/211 - Drug GMPs - 2025 SALE |
| FDA DEA GMP Master Reference Guide |
| 503B Compounding Master Guide |
| 21 CFR 111 - Dietary Supplement handbook |
| 21 CFR 200, 201 - General Drug & Drug Labeling Combination |
| 21 CFR 210/211 - Drug GMPs-ENGLISH/SPANISH |
| 21 CFR 210/211 - Drug GMPs-SPANISH |
| 21 CFR 210/211 with Drug Preambles |
| 21 CFR 210/211 with Keyword Index |
| Canadian GMP Guidelines GUI-0001 July 1, 2020 |
| US and EU GMPs with ICH Q7, Q8(R2), Q9(R1), Q10 |
| EU GMPs Chapter 1 - 9 |
| EU GMPs with ICH Q7, Q8(R2), Q9(R1) and Q10 |
| GMP - PAT Handbook |
| US, EU and Japanese GMPs |
| Chinese GMPs - NMPA - State Food & Drug Administration P.R. CHINA |
| ICH Q7 with Q7 Auditors Check List |
| ICH Q7, Q8(R2), Q9(R1), Q10 and Q11 |
| 21 CFR 4 - Regulation of Combination Products |
| Title 21 CFR Parts 1 - End Nine Volume Set |
| GLP Manufacturing Handbook - 4.5x7.5 |
| EU cGMPs for ATMP with EU GMP Chapters 1-9 |
| 21 CFR Part 207 Registration |
| ICH Q2(R2) and ICH Q14 Analytical Validation |
| Pharmaceutical Manufacturers GMP Audit Handbook |
| ICH Q7, ICH Q8(R2), ICH Q9(R1), ICH Q10 and ICH Q12 Combination |
| Standard Sterile Product Manufacturing Handbook |
| EU cGMPs for ATMP - 2018: Guidelines on Good Manufacturing Practice Specific to Advanced Therapy Medicinal Products |
| Parts 11, 606 and 1271 - Blood Cell & Tissue GMPs |
| 21 CFR Part 11, 58 GLP and OECD Series 1 GLP |
| GMP Manufacturing Handbook |
| Parts 11, 606 and 1271 - Blood, Cell & Tissue with Annex 14 |
| GMP Training, Certificate, GMP Handbook & e-Workbook |
|
- Guaranteed Lowest Price
- Quantity Discounts Available
- Always Current, Up-To-Date
- Company Logos Available
- Special Customizations
- Pocket-sized 3.75" x 6.25"
- Prep for FDA & Client Audits
- Employee Training & Reference
- Promotional "giveaways"
- Tradeshows and meetings
-
|
